Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.7965
+0.01632.09%
Volume:2.92K
Turnover:2.26K
Market Cap:38.66M
PE:-0.49
High:0.7965
Open:0.7700
Low:0.7700
Close:0.7802
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:0.12
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.31
PE(LYR):-0.49

Loading ...

Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report